Interviewing for a Cardiovascular/Pain specialty position...how are things going with Movantik, Welchol & Savaysa? Good company? Good bonus structure? Asking for a friend...
Savaysa is dead in the water will only be promoted for a little longer. How does one discover a drug class and hit the market dead last? Top that off with almost non existent managed care. Did they really advertise a position as cardiovascular if so that is a joke! If you are looking for a company with crappy products, crappy pipeline and love to be micromanaged DSI is for you. Most reps are looking to leave this joke of a company.
Savaysa is dead. Movantik is a decent drug however the expectations and goals are set way too high. A year ago nation grew by 10%. They expect 40% growth this year. You will never hit target payout unless you lie cheat and steal like the NY area. Even those reps that hit 100% growth will gross 13k payout.